Abstract
Setting
The impact on patient mortality of combined pulmonary fibrosis and emphysema (CPFE) compared with emphysema alone has never been investigated.Objective
To elucidate whether CPFE has an impact on overall mortality over that of emphysema alone.Design
We screened patients who underwent chest computed tomography (CT) scans during the period from 1 January 2001 to 31 December 2005 in a tertiary referral hospital. Patients who had both emphysema and pulmonary fibrosis, thus meeting the inclusion criteria, were defined as CPFE. Controls with emphysema alone who were matched for age, sex and the date of CT scan were randomly selected. Cox proportional regression analysis was performed to verify whether CPFE is associated with increased overall mortality.Results
We found 135 CPFE cases. In the multivariable Cox regression stratified by the presence of comorbid malignancy, CPFE had five times higher mortality risk (adjusted HR 5.10, 95%CI 1.75-14.9) in non-malignant cases, and showed a statistically insignificant trend for higher mortality risk (adjusted HR 1.70, 95%CI 0.94-2.51) in the malignant cases after adjusting for forced vital capacity, height and hypertension.Conclusion
CPFE is not rare and CPFE patients had a higher overall mortality risk than emphysema-only patients.Full text links
Read article at publisher's site: https://doi.org/10.5588/ijtld.10.0491
Citations & impact
Impact metrics
Citations of article over time
Article citations
Serum Krebs von den Lungen-6 as a potential biomarker for distinguishing combined pulmonary fibrosis and emphysema from chronic obstructive pulmonary disease: A retrospective study.
Heliyon, 10(15):e35099, 25 Jul 2024
Cited by: 0 articles | PMID: 39165953 | PMCID: PMC11333912
Leveraging Computed Tomography Imaging to Detect Chronic Obstructive Pulmonary Disease and Concomitant Chronic Diseases.
Am J Respir Crit Care Med, 210(3):281-287, 01 Aug 2024
Cited by: 0 articles | PMID: 38843079
An increased risk of pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema: a meta-analysis.
BMC Pulm Med, 23(1):221, 21 Jun 2023
Cited by: 2 articles | PMID: 37344866 | PMCID: PMC10283193
Combined Pulmonary Fibrosis and Emphysema: When Scylla and Charybdis Ally.
Cells, 12(9):1278, 28 Apr 2023
Cited by: 2 articles | PMID: 37174678 | PMCID: PMC10177208
Review Free full text in Europe PMC
Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement.
Am J Respir Crit Care Med, 206(4):e7-e41, 01 Aug 2022
Cited by: 46 articles | PMID: 35969190 | PMCID: PMC7615200
Go to all (23) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Impact of combined pulmonary fibrosis and emphysema on surgical complications and long-term survival in patients undergoing surgery for non-small-cell lung cancer.
Int J Chron Obstruct Pulmon Dis, 11:1261-1268, 09 Jun 2016
Cited by: 7 articles | PMID: 27354784 | PMCID: PMC4907478
Lung cancer risk among patients with combined pulmonary fibrosis and emphysema.
Respir Med, 108(3):524-530, 09 Jan 2014
Cited by: 45 articles | PMID: 24462477
Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation.
BMC Pulm Med, 19(1):177, 15 Oct 2019
Cited by: 14 articles | PMID: 31615505 | PMCID: PMC6792261
Combined pulmonary fibrosis and emphysema: The many aspects of a cohabitation contract.
Respir Med, 117:14-26, 07 May 2016
Cited by: 19 articles | PMID: 27492509
Review